<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Gene Therapy: A Hot Topic During the Beijing Olympics</title>
	<atom:link href="http://blog.pharmtech.com/2008/08/14/gene-therapy-a-hot-topic-during-the-beijing-olympics/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmtech.com/2008/08/14/gene-therapy-a-hot-topic-during-the-beijing-olympics/</link>
	<description>The blog of Pharmaceutical Technology magazine</description>
	<lastBuildDate>Tue, 07 Feb 2012 17:25:13 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Comet Elenin</title>
		<link>http://blog.pharmtech.com/2008/08/14/gene-therapy-a-hot-topic-during-the-beijing-olympics/comment-page-1/#comment-39185</link>
		<dc:creator>Comet Elenin</dc:creator>
		<pubDate>Fri, 22 Jul 2011 13:07:36 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=142#comment-39185</guid>
		<description>&lt;strong&gt;Nice post....&lt;/strong&gt;

[...] Beautifully explained, even though this specific report is not newly posted. I are in agreement with  the bulk of your primary details, the only suggestion we would like to share is  to view a couple more photos. Your post was appreciated. [...]...</description>
		<content:encoded><![CDATA[<p><strong>Nice post&#8230;.</strong></p>
<p>[...] Beautifully explained, even though this specific report is not newly posted. I are in agreement with  the bulk of your primary details, the only suggestion we would like to share is  to view a couple more photos. Your post was appreciated. [...]&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Richard Miller</title>
		<link>http://blog.pharmtech.com/2008/08/14/gene-therapy-a-hot-topic-during-the-beijing-olympics/comment-page-1/#comment-31034</link>
		<dc:creator>Richard Miller</dc:creator>
		<pubDate>Fri, 09 Jul 2010 17:28:34 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=142#comment-31034</guid>
		<description>I believe gene building is important, but not because of what it could do for an athlete. It is important because this is one of the ways spinal injuries might be repaired and the patient could become functional. I am sure there are many other problems that could be solved with gene building and they will only come about as the technology advances. I have seen this happen as I write a blog about resveratrol and write about the medical advances coming about from the research projects on this compound. As long as the research is completed and honest reporting is done there will be progress. There will be surprises, but that is what opens the new doors to progress.</description>
		<content:encoded><![CDATA[<p>I believe gene building is important, but not because of what it could do for an athlete. It is important because this is one of the ways spinal injuries might be repaired and the patient could become functional. I am sure there are many other problems that could be solved with gene building and they will only come about as the technology advances. I have seen this happen as I write a blog about resveratrol and write about the medical advances coming about from the research projects on this compound. As long as the research is completed and honest reporting is done there will be progress. There will be surprises, but that is what opens the new doors to progress.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

